Investing Across the IDEA™ Value Chain
At Fern, we invest across the IDEA™ value chain, from generating new health insights to enabling adoption at scale.
Our portfolio reflects our belief that better outcomes require more than breakthrough innovation. They require better decisions, better care, and the systems needed to bring innovation into everyday healthcare.
While each company addresses a different challenge, together they reflect a common belief: meaningful healthcare transformation requires progress across the entire value chain. From generating better insights, to delivering better care, to enabling adoption at scale, we back founders building the future of healthcare; starting with women's health and extending to the systems that support better outcomes for all.
Our Portfolio so far
Daye
BETTER DECISIONS
The Solution
A diagnostics and precision health platform that combines at-home biomarker collection, clinical testing, and digital care pathways to generate actionable insights across women's health.
Why It Matters
Healthcare systems can only improve outcomes when they have better information. Daye is helping address longstanding evidence and diagnostic gaps in women's health by generating new clinical insights at scale, enabling earlier intervention, more personalised care, and better decision-making for patients, providers, and researchers. By transforming routine health interactions into opportunities for continuous evidence generation, Daye is helping build the data foundation for more precise and effective healthcare.
malaica
BETTER CARE
The Solution
Malaica is a technology-enabled maternal health platform that combines dedicated midwife-led care, digital monitoring, and community support to improve access, coordination, and continuity of care throughout pregnancy and postpartum.
Why It Matters
Maternal outcomes are often limited by fragmented care pathways, workforce constraints, and inconsistent patient support. Malaica addresses these challenges through a scalable care delivery model that improves patient engagement, clinical coordination, and access to high-quality maternal care. By integrating technology with trusted healthcare professionals, Malaica demonstrates how scalable care delivery models can improve maternal outcomes while strengthening the healthcare systems needed to deliver high-quality care at scale.
Implí
BETTER ADOPTION
The Solution
A continuous hormone monitoring platform that brings real-time biological data into fertility treatment, enabling a more personalised and data-driven approach to IVF care.
Why It Matters
Many fertility treatments still rely on infrequent testing and reactive clinical decision-making. Impli helps translate continuous physiological data into actionable insights, enabling providers to make more informed decisions and patients to receive more personalised care. By embedding real-time intelligence into clinical workflows, the platform has the potential to improve outcomes while supporting the broader adoption of precision medicine in reproductive healthcare.
Building the future of healthcare?
We're looking for founders transforming how health is understood, delivered, and adopted. If you're building solutions that improve outcomes and can scale across healthcare systems, we'd love to hear from you. Submit your pitch deck or get in touch.
